MONDAY, Sept. 15, 2025 (HealthDay News) — Health workers in southern Kasai province have started giving Ebola vaccines as officials race to contain the latest outbreak, the World Health Organization (WHO) said. So far, at least 68 suspected cases and 16 deaths have been reported since the outbreak was declaredContinue Reading
FRIDAY, Sept. 12, 2025 (HealthDay News) — County jail inmates who receive medication to treat their opioid addiction have a lower risk of overdose after their release, a new study reports. They’re also significantly more likely to continue their addiction treatment, researchers reported Sept. 10 in The New England JournalContinue Reading
FRIDAY, Sept. 12, 2025 (HealthDay News) — RSV can make even healthy, full-term babies sick enough to land in the hospital or require intensive care, a new study says. In fact, more than half of RSV-infected infants and children who required intensive care or prolonged hospitalization were born at termContinue Reading
First and only drug releasing system is indicated for patients with BCG-unresponsive non-muscle-invasive bladder cancer seeking bladder preservationContinue Reading
New guidance aims to increase nonopioid choices for chronic pain while combating misuseContinue Reading
PD-1/PD-L1 immunotherapies for several metastatic cancers also made the list of essential drugsContinue Reading
TUESDAY, Sept. 9, 2025 (HealthDay News) — Medicaid serves a key role in helping opioid addicts get the treatment they need, a new study says. Prescription rates for the anti-opioid medication buprenorphine increased more than 27% in states that expanded Medicaid between 2018 and 2024, researchers reported in the SeptemberContinue Reading
The recombinant treatment is now approved for prophylactic use in adults and for treating bleeding episodes and perioperative use in childrenContinue Reading
The purpose of the list is to keep unverified and unapproved GLP-1 drug ingredients from entering the countryContinue Reading
FRIDAY, Sept. 5, 2025 (HealthDay News) — A single dose of LSD eased anxiety symptoms for many folks and the benefits lasted up to three months, a new study reports. The findings were published Sept. 4 in the Journal of the American Medical Association. Researchers tested several doses of LSDContinue Reading